Patient Upside Murky In Drug-Price Cases

Main Category: Pharmacy / Pharmacist
Also Included In: Pharma Industry / Biotech Industry;  Health Insurance / Medical Insurance;  Litigation / Medical Malpractice
Article Date: 12 Jun 2009 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated

"The prices of hundreds of brand-name drugs are about to be cut 4%, and millions of Americans may soon receive a check in the mail as compensation for having overpaid for their prescriptions," but "the extent to which the average consumer will benefit isn't yet clear," the Wall Street Journal reports. "The price cuts and expected payments are the result of federal class-action settlements involving two drug-price publishers and a major drug wholesaler that were accused of inflating drug prices."

The price rollbacks may save $100 billion in the first year, with about $100 million of that amount "saved directly by patients, while the balance would accrue to employers and private health insurers." But critics say that "because drug pricing is so opaque and complex, patients won't likely get meaningful and long-lasting relief." Eighty-four million dollars may go to pay attorney fees, and pharmacies are still trying to stop the price rollbacks, "which could shrink their profit margins." In addition to price cuts, under the settlement, "uninsured patients who filled prescriptions for such widely used drugs as Pfizer Inc.'s Lipitor, Sanofi Aventis SA's Ambien and hundreds of other medicines between August 2001 and Jan. 23, 2009 are eligible for reimbursement checks from an about $60 million pot that has been set aside." According to testimony for the plaintiffs, the extra costs for insurers and patients comes to $2.9 billion. Many insured patients were also likely "affected indirectly because the higher costs added to a rise in health-insurance premiums." In order to qualify for the reimbursement funds, patients must have "kept good records" of their purchases and must submit claim forms by July 9 to a settlement administrator" (Rubenstein, 6/11).

This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org.

© Henry J. Kaiser Family Foundation. All rights reserved.



Article adapted by Medical News Today from original press release.
Visit our pharmacy / pharmacist section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Patient Upside Murky In Drug-Price Cases." Medical News Today. MediLexicon, Intl., 12 Jun. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/153615.php>

APA
Kaiser. (2009, June 12). "Patient Upside Murky In Drug-Price Cases." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/153615.php.

Please note: If no author information is provided, the source is cited instead.


Pharmacy / Pharmacist

Most Popular Articles



Follow Our Pharmacy News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharmacy / Pharmacist Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »